These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

787 related articles for article (PubMed ID: 33986723)

  • 21. Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like.
    Giannini R; Moretti S; Ugolini C; Macerola E; Menicali E; Nucci N; Morelli S; Colella R; Mandarano M; Sidoni A; Panfili M; Basolo F; Puxeddu E
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3557-3575. PubMed ID: 30882858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological perspective on the effects of tumor-associated macrophages in the tumor microenvironment surrounding papillary thyroid carcinoma.
    Can NY; Ayturk S; Celik M; Sezer YA; Ozyilmaz F; Tastekin E; Sut N; Ustun F; Bulbul BY; Puyan FO; Guldiken S
    Pol J Pathol; 2016; 67(4):332-344. PubMed ID: 28547960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
    Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
    Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
    Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
    Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
    Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-324-5p/PTPRD/CEBPD axis promotes papillary thyroid carcinoma progression via microenvironment alteration.
    Yang Y; Xia S; Zhang L; Wang W; Chen L; Zhan W
    Cancer Biol Ther; 2020 Jun; 21(6):522-532. PubMed ID: 32151175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
    Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
    Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of neutrophils-to-lymphocytes ratio (NLR), PD-L1 expression, and tumor immune microenvironment in laryngeal cancer.
    Franz L; Alessandrini L; Fasanaro E; Gaudioso P; Carli A; Nicolai P; Marioni G
    Ann Diagn Pathol; 2021 Feb; 50():151657. PubMed ID: 33189034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune Profiling of Advanced Thyroid Cancers Using Fluorescent Multiplex Immunohistochemistry.
    Ahn J; Jin M; Song E; Ryu YM; Song DE; Kim SY; Kim TY; Kim WB; Shong YK; Jeon MJ; Kim WG
    Thyroid; 2021 Jan; 31(1):61-67. PubMed ID: 32611231
    [No Abstract]   [Full Text] [Related]  

  • 30. Immune Escape Mechanism is Impaired in the Microenvironment of Thyroid Lymph Node Metastasis.
    Cunha LL; Nonogaki S; Soares FA; Vassallo J; Ward LS
    Endocr Pathol; 2017 Dec; 28(4):369-372. PubMed ID: 28730569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunotherapy for patients with thyroid cancer: a comprehensive appraisal.
    Pinheiro Neto A; Lucchesi HL; Valsecchi VADS; Ward LS; Cunha LL
    Chin Clin Oncol; 2024 Jun; 13(3):36. PubMed ID: 38859604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer.
    Hou Y; Lin B; Xu T; Jiang J; Luo S; Chen W; Chen X; Wang Y; Liao G; Wang J; Zhang J; Li X; Xiang X; Xie Y; Wang J; Peng S; Lv W; Liu Y; Xiao H
    Nat Commun; 2024 Jul; 15(1):5555. PubMed ID: 39030177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune cell infiltrate-associated dysregulation of DNA repair machinery may predispose to papillary thyroid carcinogenesis.
    Nicolson NG; Brown TC; Korah R; Carling T
    Surgery; 2020 Jan; 167(1):66-72. PubMed ID: 31439400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the
    Chevolet I; Speeckaert R; Schreuer M; Neyns B; Krysko O; Bachert C; Hennart B; Allorge D; van Geel N; Van Gele M; Brochez L
    Oncoimmunology; 2015 Mar; 4(3):e982382. PubMed ID: 25949897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment.
    Zhang Y; Guoqiang L; Sun M; Lu X
    Cancer Biol Med; 2020 Feb; 17(1):32-43. PubMed ID: 32296575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-cell programming in pancreatic adenocarcinoma: a review.
    Seo YD; Pillarisetty VG
    Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current and future immunotherapies for thyroid cancer.
    Antonelli A; Ferrari SM; Fallahi P
    Expert Rev Anticancer Ther; 2018 Feb; 18(2):149-159. PubMed ID: 29241377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune profiling identifies CD8
    Chen Z; Guo ML; Li YY; Yan K; Li L; Shen F; Guan H; Liu QZ; Xu B; Lian ZX
    Front Immunol; 2022; 13():894919. PubMed ID: 36420264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses in the thyroid cancer microenvironment: making immunotherapy a possible mission.
    Mould RC; van Vloten JP; AuYeung AWK; Karimi K; Bridle BW
    Endocr Relat Cancer; 2017 Dec; 24(12):T311-T329. PubMed ID: 28912377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.